Mucowind Injection (Ambroxol Hydrochloride)

Adult administration

Administer slowly via intravenous injection at a dose of 15 mg once, 2 to 3 times a day as Ambroxol Hydrochloride. In severe cases, the dose can be escalated up to 30 mg, and it can be administered as a drip intravenous injection in combination with normal saline or Ringer’s solution.

Child administration

Administer slowly via intravenous injection at a dose of 1.2 – 1.6 mg per kg of body weight per day. Ages 5 and above: 15 mg once, 2 to 3 times a day Ages 2 to 4: 7.5 mg once, 3 times a day Under 2 years: 7.5 mg once

Due to the fact that this drug is an ampule injection, there is a risk of glass fragments entering the injection when cutting the glass container, which can cause side effects. Special care should be taken when used by children or the elderly to ensure no glass fragments are introduced. This drug should not be administered to individuals allergic to it or its components. It should be administered with caution to patients with poor kidney function, severe liver disease, and infants under 2 years of age. Serious skin disorders may rarely occur during treatment, so if any new damage appears on the skin or mucous membranes, the drug should be discontinued immediately, and medical professionals should be informed. Gastrointestinal symptoms such as dyspepsia, nausea, vomiting, heartburn, and dry mouth may rarely occur, and reports also include abdominal discomfort, diarrhea, constipation, and loss of appetite. Furthermore, rare symptoms such as skin rash or severe allergic reactions, breathing difficulties, and facial swelling may occur, and if such symptoms arise, immediate medical attention should be sought. In the respiratory system, inflammatory rhinitis may develop, and in the nervous system, there may be altered sensation of the tongue or changes in taste, and rarely sensations of oral paralysis or arm paralysis. This drug may increase the concentration of antibiotics in bronchial or pulmonary secretions when used with certain antibiotics, so caution is needed when used in combination. Use during pregnancy is not recommended, especially in the first three months, and it should be administered with caution in pregnant women as it can cross the placenta. Breastfeeding women should only use this medication if the benefits are deemed to outweigh the risks, as it may pass into breast milk. Elderly patients may have decreased bodily functions, so dosage adjustments and other precautions are necessary. No specific symptoms have been reported with overdose, but appropriate symptomatic treatment may be required if adverse reactions occur. During injection, headaches, leg pain, and severe fatigue may occur, so it is advisable to inject slowly. This drug should only be mixed with normal saline or Ringer's solution and should be administered as a drip infusion. It should be used within 24 hours of mixing. Keep in a safe location out of reach of children.

Serious side effects

Urticaria, angioedema, respiratory distress, severe acute anaphylactic reactions (including anaphylactic shock), Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell syndrome)

Mild side effects

• Dyspepsia
• nausea
• vomiting
• heartburn
• dry mouth
• gastrointestinal discomfort
• abdominal bloating
• stomach pain
• diarrhea
• constipation

This drug should be stored in a light-protective sealed container at room temperature between 1 and 30 degrees Celsius. Proper storage can help maintain the effectiveness of the drug for a longer time.

Appearance

A clear, colorless liquid contained in a brown ampule

Package unit

2mL/ampule*50